Version 2.78

Description

Rosoxacin (also known as acrosoxacin, tradename Eradacil) is a quinolone antibiotic indicated for the treatment of urinary tract infections and certain sexually transmitted diseases. Rosoxacin is not available in the United States. It was developed by Sanofi-Synthelabo (now part of sanofi-aventis). It is classified as first generation. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Rosoxacin

Basic Part Properties

Part Display Name
Rosoxacin
Part Type
Component (Describes the core component or analyte measured)
Created On
2000-05-04
Construct for LOINC Short Name
Rosoxacin

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP16336-7
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP16336-7

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 罗索沙星
Synonyms: 吡喹酸;罗索沙新;Rosoxacin;1-ethyl-4-oxo-7-(4-pyridyl)quinoline-3-carboxylic acid;1-ethyl-4-oxo-7-(pyridin-4-yl)-1,4-dihydroquinoline-3-carboxylic acid;CAS 40034-42-2;EINECS 254-758-4;C17H14N2O3
fr-CA French (Canada) Rosoxacine
et-EE Estonian (Estonia) Rosoksatsiin
es-ES Spanish (Spain) Rosoxacina
it-IT Italian (Italy) Rosoxacina
tr-TR Turkish (Turkey) Rosoksazin
ru-RU Russian (Russian Federation) Розоксацин
nl-NL Dutch (Netherlands) rosoxacine
fr-BE French (Belgium) Rosoxacine